We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Health-related quality of life in Chinese SLE patients: evidence from 1568 SLE patients and 2610 healthy controls

    Objective

    To investigate the effects of systemic lupus erythematosus (SLE) on health-related quality of life (HRQOL), the relationship between disease...

    Yu-Hua Wang, Hong-Yu Sun, ... Yan-Feng Zou in Quality of Life Research
    Article 12 October 2023
  2. Possible Role of Dysbiosis of the Gut Microbiome in SLE

    Purpose of Review

    The resident gut microbiota serves as a double-edged sword that aids the host in multiple ways to preserve a healthy equilibrium and...

    F. Naz Cemre Kalayci, Seza Ozen in Current Rheumatology Reports
    Article 22 September 2023
  3. Subclinical pleuro-pulmonary disease in patients with SLE: functional and radiological methods

    Background

    Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with highest prevalence of chest involvement; however, early...

    Hanaa S. Hamed, Mohammed M. N. Abozaid, Enas Mekawy in The Egyptian Journal of Bronchology
    Article Open access 19 February 2024
  4. Targeting DORIS Remission and LLDAS in SLE: A Review

    Remission is the established therapeutic goal for patients with systemic lupus erythematosus (SLE) and is currently defined by the widely adopted...

    Agner R. Parra Sánchez, Ronald F. van Vollenhoven, ... Alessandro Sorrentino in Rheumatology and Therapy
    Article Open access 05 October 2023
  5. Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity

    Background

    Type 2 systemic lupus erythematosus (SLE) symptoms, including fatigue, fibromyalgia, and brain fog, contribute to poor health-related...

    Jennifer L. Rogers, Megan E. B. Clowse, ... Amanda M. Eudy in Clinical Rheumatology
    Article 26 February 2024
  6. Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants

    The past few years have provided important insights into the genetic architecture of systemic autoimmunity through aggregation of findings from...

    Carola G. Vinuesa, Nan Shen, Thuvaraka Ware in Nature Reviews Nephrology
    Article 12 July 2023
  7. Interaction of 5-HTTLPR and SLE disease status on resting-state brain function

    Background

    Neuropsychiatric involvement in systemic lupus erythematosus (SLE) is a common clinical manifestation. In SLE patients, cerebral function...

    Lihua Ma, Yifan Yang, ... Jian Xu in Arthritis Research & Therapy
    Article Open access 31 January 2024
  8. Platelet ındices as potential biomarkers of perinatal outcomes in women with SLE during pregnancy

    Aim

    This study aimed to assess the platelet parameters and their prognostic value for perinatal outcomes in pregnant women with systemic lupus...

    Fatih Akkuş, Şükran Doğru in Archives of Gynecology and Obstetrics
    Article 29 March 2024
  9. Negative ANA-IIF in SLE patients: what is beyond?

    Abstract

    The antinuclear antibody (ANA) test has high sensitivity in diagnosing and classifying systemic lupus erythematosus (SLE).

    Objectives ...
    Hanan Sayed M. Abozaid, Hesham M. Hefny, ... Amal H. Ali in Clinical Rheumatology
    Article Open access 04 April 2023
  10. Identification of EPSTI1 as a new potential biomarker for SLE based on GEO database

    Objective

    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with highly heterogeneous. The aim of this study is to find the key genes...

    Yiying Yang, Huali Zhang, ... Muyao Guo in Clinical Rheumatology
    Article 20 March 2024
  11. Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients

    Systemic lupus erythematosus (SLE) is a common autoimmune disease with a polymorphic clinical presentation involving multisystem damages with...

    Mengyao Liu, Shenglong Wang, ... Weijie Wang in Clinical Rheumatology
    Article 04 July 2024
  12. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE)

    Antiphospholipid antibodies (APLA) are present in one-third of systemic lupus erythematosus (SLE) patients, and they are associated with both...

    Vineeta Shobha, Liza Rajasekhar, ... Amita Aggarwal in Rheumatology International
    Article 12 December 2023
  13. Presentation of SLE after COVID vaccination in a pediatric patient

    Background

    The outbreak of severe acute respiratory syndrome coronavirus 2 has had an enormous impact on global health. Vaccination remains one of the...

    Meghan Corrigan Nelson, Heather Rytting, ... Baruch Goldberg in BMC Rheumatology
    Article Open access 20 December 2022
  14. YKL-40 in serum: a promising biomarker of juvenile SLE and strongly correlated with disease duration

    Background

    The biological function of YKL-40 is not well determined in different inflammatory and autoimmune diseases; however, some data highlighted...

    Asmaa A. Ali, Rasha N. Yousef, ... Mervat E. Behiry in Irish Journal of Medical Science (1971 -)
    Article Open access 24 October 2023
  15. Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study

    We investigated associations of obesity and tobacco smoking with health-related quality of life (HRQoL), pain, fatigue, and functional impairment in...

    Alvaro Gomez, Ioannis Parodis, Christopher Sjöwall in Rheumatology International
    Article Open access 07 March 2024
  16. Assessment of peripapillary retinal nerve fiber layer thickness and vessel density in newly diagnosed SLE patients without ocular symptoms

    Purpose

    This study aims to assess peripapillary retinal nerve fiber layer thickness (pRNFLT) and peripapillary vessel density (PVD) in patients with...

    Article 18 July 2023
  17. Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study

    Objective

    To account for heterogeneity in systemic lupus erythematosus (SLE) and bridge discrepancies between patient- and physician-perceived SLE...

    Kai Sun, Amanda M. Eudy, ... Jennifer L. Rogers in Journal of Patient-Reported Outcomes
    Article Open access 21 December 2023
  18. Nailfold capillaroscopy in Egyptian systemic lupus erythematosus (SLE) patients: correlation with demographic features and serum levels of IL 17A and IFNs I

    Background

    In SLE patients, cytokines are linked to endothelial cell damage. Nailfold capillaroscopy (NFC) is a simple method for evaluating...

    Mohamed Nasser, Mary Wadie, ... Azza El Amir in Egyptian Rheumatology and Rehabilitation
    Article Open access 19 September 2023
  19. Emerging concepts of type I interferons in SLE pathogenesis and therapy

    Type I interferons have been suspected for decades to have a crucial role in the pathogenesis of systemic lupus erythematosus (SLE). Evidence has now...

    Antonios Psarras, Miriam Wittmann, Edward M. Vital in Nature Reviews Rheumatology
    Article 12 September 2022
  20. Development and validation of the systemic lupus erythematous scale amongst the system of quality of life instruments for chronic diseases QLICD-SLE (V2.0)

    Objective

    The present study is aimed to develop and validate a quality of life scale for systemic lupus erythematosus (SLE) patients with Chinese...

    Yuxi Liu, Jiaqi Zhang, ... Chonghua Wan in Health and Quality of Life Outcomes
    Article Open access 29 November 2023
Did you find what you were looking for? Share feedback.